The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APPswe Cell Model of AD

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00199

Related search